<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Involvement of <z:chebi fb="3" ids="16335">adenosine</z:chebi> and <z:chebi fb="3" ids="15422">adenosine triphosphate</z:chebi>-sensitive <z:chebi fb="120" ids="26216">potassium</z:chebi> (KATP) channels in the development of ischemic tolerance has been suggested in global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, but has not been studied extensively in focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This study evaluated modulating effects of <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> DPCPX (8-<z:chebi fb="0" ids="52880">cyclopentyl</z:chebi>-1,3-dipropylxanthine) and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> KATP channel blocker 5HD (5-hydroxydecanoate) on the development of tolerance to focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="2" pm="."><plain>Preconditioning with 30-minute middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) reduced cortical and subcortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volume following 120-minute MCAO (test <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) given 72 hours later </plain></SENT>
<SENT sid="3" pm="."><plain>The neuroprotective effect of preconditioning was attenuated by 0.1 mg/kg DPCPX given before conditioning <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (30-minute MCAO), but no influence was provoked when it was administered before test <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>DPCPX had no effect on <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after conditioning or test <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> when given alone </plain></SENT>
<SENT sid="5" pm="."><plain>The preconditioning-induced neuroprotection disappeared when 30 mg/kg 5HD was administered before test <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest a possible involvement of <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1 receptors during conditioning <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> KATP channels during subsequent severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the development of tolerance to focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>